PATCHLESS PATCH Trademark
Trademark Overview
On Friday, August 15, 2003, a trademark application was filed for PATCHLESS PATCH with the United States Patent and Trademark Office. The USPTO has given the PATCHLESS PATCH trademark a serial number of 78288099. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 5, 2012. This trademark is owned by Acrux DDS Pty Ltd. The PATCHLESS PATCH trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and veterinary preparations for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for transdermal delivery for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for transmucosal delivery for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; phar...
General Information
| Serial Number | 78288099 |
| Word Mark | PATCHLESS PATCH |
| Filing Date | Friday, August 15, 2003 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, October 5, 2012 |
| Registration Number | 3062095 |
| Registration Date | Tuesday, February 28, 2006 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 6, 2005 |
Trademark Statements
| Goods and Services | Pharmaceutical and veterinary preparations for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for transdermal delivery for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for transmucosal delivery for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for hormone-replacement therapy; pharmaceutical compositions containing active agents for the treatment of diseases and conditions of the central nervous system; pharmaceutical compositions for non-occlusive transdermal and transmucosal delivery which form a reservoir or deposit within the skin or membrane for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions providing transdermal and transmucosal delivery of hormones such as estradiol and other physiologically active agents acting on the central nervous system such as fentanyl |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, October 5, 2012 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Acrux DDS Pty Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | West Melbourne 3003
AU |
| Party Name | Acrux DDS Pty Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | West Melbourne 3003
AU |
| Party Name | Acrux DDS Pty Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | West Melbourne 3003
AU |
Trademark Events
| Event Date | Event Description |
| Friday, October 5, 2012 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, February 28, 2006 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, December 6, 2005 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 16, 2005 | NOTICE OF PUBLICATION |
| Friday, October 14, 2005 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, September 16, 2005 | ASSIGNED TO LIE |
| Saturday, September 10, 2005 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, September 9, 2005 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 6, 2005 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 6, 2005 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 7, 2005 | NON-FINAL ACTION MAILED |
| Sunday, March 6, 2005 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 17, 2004 | AMENDMENT FROM APPLICANT ENTERED |
| Friday, November 19, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 9, 2004 | PAPER RECEIVED |
| Thursday, September 16, 2004 | AMENDMENT FROM APPLICANT ENTERED |
| Tuesday, August 17, 2004 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 16, 2004 | ASSIGNED TO LIE |
| Tuesday, August 17, 2004 | PAPER RECEIVED |
| Tuesday, February 17, 2004 | NON-FINAL ACTION MAILED |
| Friday, January 30, 2004 | ASSIGNED TO EXAMINER |
| Monday, November 17, 2003 | PAPER RECEIVED |
